在平原之外激活人类15-lipoxygenase-1:发现非芳香调节剂
Marina Somaraki1, Ioannis Zachilas2, Elvira Tsapinou2
1Laboratory of Biophysical Chemistry, Department of Chemistry, University of Crete, 70013 Voutes, Heraklion, Greece. n.eleftheriadis@uoc.gr.
研究人员使用独特的五个成员环架发现了15-氧酶-1 (15-LOX-1) 的新型激活剂和抑制剂. 这通过识别特定的酶调节剂来扩大治疗选择.
科学领域:
- 药用化学 医学化学
- 酶学 是一种酶学.
- 药物发现 药物发现 药物发现
背景情况:
- 调节酶活性的小分子是关键的治疗策略.
- 虽然已知人类15-lipoxygenase-1 (15-LOX-1) 抑制剂,但激活剂仍未被发现.
研究的目的:
- 确定新型调节剂,特别是15-氧基酶-1 (15-LOX-1) 的激活剂.
- 为了探索15-LOX-1调制的非芳香,富含sp3的五个成员环架.
主要方法:
- 新型支架的系统结构-活动关系 (SAR) 分析.
- 跨不同物种和基板的选择性研究.
- 酶运动分析和分子建模.
主要成果:
- 确定了γ-乳酸衍生物作为15-LOX-1抑制剂.
- 发现了布丁诺利德和环坦衍生物作为15-LOX-1激活剂.
- 确定β位置原子标识和γ位置替代物对15-LOX-1活动调制具有关键影响.
结论:
- 这些发现扩大了15-LOX-1调制器的化学空间.
- 已识别的化合物表现出对物种和基质的特定影响.
- 化合物通过竞争机制起作用,为选择性酶调节器的开发提供了潜力.
更多相关视频
08:09Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
相关概念视频
Radical Autoxidation
Positive Regulator Molecules
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Biosynthesis of Lipids
Ligand Binding and Linkage
